📍 WASHINGTON D.C., USA
31.10.2026
FDA Moves to Rescind Approval for Autoimmune Drug Tavneos Over Tainted Data
The Food and Drug Administration has initiated formal administrative proceedings to revoke its commercial approval of the rare disease therapeutic Tavneos following revelations of compromised clinical trial data. Agency ...